GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Rumour Verification - Regulation 30(11)

Regulatory & Legal View source PDF Explain this filing

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹2900.00

prior close

₹2853.00

announcement price

In-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+1.1%-2.0% vs market

Pharmaceuticals peers, median of 150sector+0.7%-1.6% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Midcap 150 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.3

15m

-0.4

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9+1.1-2.0+0.7-1.6

Next day

-2.7+0.9-3.7-0.2-2.6

-5.9+0.0-6.0-1.9-4.1

-7.7+0.3-8.0-1.1-6.6

-8.9-1.1-7.7-2.0-6.9

-7.6-0.5-7.1-1.6-6.1

-4.5-0.1-4.4-1.0-3.5

15d

-4.7+0.1-4.8-2.3-2.4

-2.0+0.3-2.3-1.8-0.2

-6.0+2.2-8.2-3.6-2.5

-8.3+5.0-13.3-3.1-5.3

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Exchanges (NSE and BSE) asked GlaxoSmithKline Pharmaceuticals India to clarify a Moneycontrol article titled 'Trump Tariff News Live: GSK and AstraZeneca among top companies told to cut US prices or else'. The company clarified that the news item pertains to its UK ultimate parent, GSK plc, and NOT to the Indian listed entity. GlaxoSmithKline Pharmaceuticals India stated it has no additional information on the matter and does not see any bearing on its share price. No undisclosed price-sensitive information exists in the company's view.

Likely market impact

Neutral to slightly positive for the Indian stock, as the company is distancing itself from negative news affecting its UK parent. Retail investors should note that this is a routine clarification confirming the Indian listed company is not directly impacted by the Trump tariff-related US pricing pressure story.